Medical device manufacturer
Zeus Scientific, Inc.
Zeus Scientific, Inc. holds 141 FDA 510(k) clearances across 48 product codes. Median elapsed review time is 90 days. openFDA lists 12 recall records naming the company. FDA publishes it under 6 different spellings, all counted here as one company.
Updated · ingest status · JSON
- 510(k) clearances
- 141
- Product codes
- 48
- Median review
- 90 days
- Recall records
- 12
How does FDA spell Zeus Scientific, Inc.?
FDA publishes this company under 6 different spellings across its datasets. Every figure on this page counts all of them as one company, which is why the totals here are higher than a search for any single spelling would give you.
| As FDA published it | Dataset | Matched by |
|---|---|---|
| ZEUS SCIENTIFIC LLC | device/registrationlisting | normalised |
| Zeus Scientific | device/510k | normalised |
| Zeus Scientific Inc | device/recall | normalised |
| Zeus Scientific, Inc. | device/enforcement | normalised |
| Zeus Scientific, Inc. | device/recall | normalised |
| Zeus Scientific, Inc. | device/510k | normalised |
Merges are measured against a hand-labelled sample and held above 98% precision. Pairs the matcher is unsure of are queued for a person rather than merged, because two genuinely different firms with similar names is the error that would corrupt every count on this page.
Which product codes does Zeus Scientific, Inc. file in?
48 product codes, ranked by how much they file in each.
| Code | Device | Clearances | Median review | Latest |
|---|---|---|---|---|
| LSR | Reagent, Borrelia Serological Reagent | 13 | 112 days | |
| LLL | Extractable Antinuclear Antibody, Antigen And Control | 9 | 54 days | |
| MID | System, Test, Anticardiolipin Immunological | 9 | 64 days | |
| MOB | Test System, Antineutrophil Cytoplasmic Antibodies (Anca) | 8 | 76 days | |
| DHN | Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control | 6 | 14 days | |
| LJM | Antinuclear Antibody (Enzyme-Labeled), Antigen, Controls | 6 | 63 days | |
| GQL | Antisera, Fluorescent, Herpesvirus Hominis 1,2 | 5 | 106 days | |
| LFX | Enzyme Linked Immunoabsorbent Assay, Rubella | 5 | 210 days | |
| LFZ | Enzyme Linked Immunoabsorbent Assay, Cytomegalovirus | 5 | 93 days | |
| LSE | Epstein-Barr Virus, Other | 5 | 147 days | |
| LFY | Enzyme Linked Immunoabsorbent Assay, Varicella-Zoster | 4 | 133 days | |
| LGD | Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii | 4 | 60 days | |
| MST | Antibodies, Gliadin | 4 | 45 days | |
| DDC | Thyroglobulin, Antigen, Antiserum, Control | 3 | 46 days | |
| DHR | System, Test, Rheumatoid Factor | 3 | 50 days | |
| JZO | System, Test, Thyroid Autoantibody | 3 | 18 days | |
| LJZ | Enzyme Linked Immunoabsorbent Assay, Mycoplasma Spp. | 3 | 118 days | |
| LKJ | Antinuclear Antibody, Antigen, Control | 3 | 31 days | |
| LLM | Test, Antigen, Nuclear, Epstein-Barr Virus | 3 | 184 days | |
| DBM | Antimitochondrial Antibody, Indirect Immunofluorescent, Antigen, Control | 2 | 18 days | |
| GLZ | Antigens, If, Toxoplasma Gondii | 2 | 42 days | |
| GRZ | Antisera, Fluorescent, All, Mycoplasma Spp. | 2 | 329 days | |
| JRY | Antiserum, Fluorescent, Epstein-Barr Virus | 2 | 21 days | |
| LGC | Enzyme Linked Immunoabsorbent Assay, Herpes Simplex Virus, Non-Specific | 2 | 70 days | |
| LHL | Reagents, Antibody, Legionella, Direct & Indirect Fluorescent | 2 | 54 days |
Showing the 25 they file in most, of 48.
Median review is elapsed calendar days between date received and decision date, as published by FDA. It is not FDA review days — the two differ whenever the agency stops the clock for an additional information request.
Source: openFDA device/510k · retrieved
Has Zeus Scientific, Inc. had a recall?
openFDA lists 12 recall records naming this company across its whole history. A recall record covers one firm's corrective action and may span many device lots.
Z-0602-2024Class IIOpen, ClassifiedMYL
The organization completed a product improvement process to the conjugate found within the certain ELISA kits. This modification was not reviewed and approved by FDA prior to its implementation.
Z-0603-2024Class IIOpen, ClassifiedMYL
The organization completed a product improvement process to the conjugate found within the certain ELISA kits. This modification was not reviewed and approved by FDA prior to its implementation.
Z-3026-2020Class IITerminatedMYM
FDA inspection identified that due to increased positivity (false positives) on the Parvovirus B19 ELISA Test System, the firm assigned a new Correction Factor and new lot number to the remainder of the affected lot, and distributed the reworked product to the customer.
Z-2494-2019Class IITerminated
Assay files used on the open Dynex DSX Instrument to process IVD ELISA samples-programming error results in well H6 being skipped for the addition of the TMB substrate. Well H6 will generate a negative result regardless of whether the patient was negative or positive for that antibody. This could result in a potential false negative result for that assay for any patients tested in well H6.
Z-1500-2012TerminatedLJY
Select lots of AtheNA Multi-Lyte MMV Test System have lost reactivity and may produce false positive results in seronegative patients who have not been previously affected with or vaccinated against Mumps.
Showing the 5 most recently initiated of 12.
Recall class comes from openFDA's enforcement endpoint, which does not carry every recall — where it is missing, none is shown rather than guessed. Recall class I is the most serious kind of recall; device class I is the least risky kind of device, and the two are never mixed here.
Source: openFDA device/recall · retrieved
What has Zeus Scientific, Inc. cleared recently?
| 510(k) | Device | Code | Decision | Elapsed days |
|---|---|---|---|---|
| K250814 | Alegria Flash SSA-60; Alegria Flash SSA-52; Alegria FLash SSB | OBE | 417 | |
| K250666 | Alegria Flash CTD Screen | LLL | 231 | |
| K250408 | Alegria Flash ENA Screen | LLL | 218 | |
| K243776 | Anti-Neutrophil Cytoplasmic Antibodies (Ethanol-Fixed); Anti-Neutrophil Cytoplasmic Antibodies (Formalin-Fixed) | MOB | 149 | |
| K231616 | ZEUS IFA(TM) nDNA Test System, ZEUS dIFine | KTL | 90 | |
| K230863 | ZEUS Solinas Borrelia VlsE1/pepC10 IgG/IgM Test System; ZEUS Solinas Borrelia VlsE1/pepC10 IgG/IgM Control Kit | LSR | 106 | |
| K201956 | Zeus IFA ANA HEp-2 Test System, Zeus dIFine | DHN | 654 | |
| K191398 | ZEUS ELISA Borrelia VlsE1/pepC10 IgG/IgM Test System; ZEUS ELISA Borrelia burgdorferi IgG Test System | LSR | 66 | |
| K191240 | ZEUS ELISA Borrelia VlsE1/pepC10 IgG/IgM Test System; ZEUS ELISA Borrelia burgdorferi IgM Test System | LSR | 82 | |
| K190907 | ZEUS ELISA Borrelia VlsE1/pepC10 IgG/IgM Test System; ZEUS ELISA Borrelia burgdorferi IgG/IgM Test System | LSR | 112 |
Source: openFDA device/510k · retrieved
Where is Zeus Scientific, Inc. registered?
FDA lists 1 registered establishment for this company in US.
Registration means the firm has told FDA it makes or distributes devices from that site. It is not a clearance, an approval or an endorsement.
Watch what Zeus Scientific, Inc. files next
Get an email when this company clears a new device, or when anything is recalled in a product code you follow.
Data on this page comes from FDA's public openFDA API and is US public domain (CC0). DeviceSignal is an independent commercial service and is not affiliated with the U.S. Food and Drug Administration. Information only, not regulatory advice. Verify anything you rely on against open.fda.gov.